Ex vivo data from patient-derived micro-tumors (PDMs) co-cultured with autologous tumor-infiltrating lymphocytes (TILs) corroborate these findings, with the combination of anti-CSF1R and anti-PD-1 promoting cytotoxic activity [44]. The gene discussed is CSF1R; the disease is neoplasm.